Bank of New York Mellon’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $290K | Buy |
53,358
+7,437
| +16% | +$40.4K | ﹤0.01% | 3799 |
|
2025
Q1 | $159K | Hold |
45,921
| – | – | ﹤0.01% | 3915 |
|
2024
Q4 | $473K | Sell |
45,921
-342
| -0.7% | -$3.52K | ﹤0.01% | 3535 |
|
2024
Q3 | $627K | Sell |
46,263
-15,336
| -25% | -$208K | ﹤0.01% | 3378 |
|
2024
Q2 | $801K | Buy |
61,599
+7,373
| +14% | +$95.8K | ﹤0.01% | 3314 |
|
2024
Q1 | $512K | Sell |
54,226
-3,144
| -5% | -$29.7K | ﹤0.01% | 3505 |
|
2023
Q4 | $629K | Sell |
57,370
-180
| -0.3% | -$1.98K | ﹤0.01% | 3417 |
|
2023
Q3 | $368K | Buy |
57,550
+4,197
| +8% | +$26.8K | ﹤0.01% | 3706 |
|
2023
Q2 | $257K | Buy |
53,353
+16,916
| +46% | +$81.4K | ﹤0.01% | 3891 |
|
2023
Q1 | $150K | Sell |
36,437
-657
| -2% | -$2.71K | ﹤0.01% | 3999 |
|
2022
Q4 | $160K | Buy |
+37,094
| New | +$160K | ﹤0.01% | 4032 |
|